Shantel
Key Takeaways
- Clario, a leading healthcare research technology company, announces the appointment of a new CFO and promotions within its executive leadership team.
- Jason Knoblauch, formerly with Curia, joins as the new CFO.
- Three executives, Lauren Misztal, Dr. Joyce Suhy, and Kristina Lowe receive promotions reflecting their contributions to Clario.
- The strategic appointments underscore Clario’s commitment to growth, customer service, and scientific innovation.
A New Era for Clario
As a leading healthcare research technology company, Clario has always prided itself on the strength and dynamism of its leadership team. This dedication to excellence is being further enhanced by the recent announcement of strategic appointments and promotions to its executive leadership.
Appointment of Jason Knoblauch as Chief Financial Officer
One of the key changes is the appointment of Jason Knoblauch as the new Chief Financial Officer (CFO). Prior to joining Clario, Jason served in financial leadership roles at Curia and PPD, boasting a career enriched with comprehensive financial expertise. His educational background, consisting of a Bachelor of Science from Creighton University and a Master of Science from the University of Virginia, augments his professional acumen.
“Jason brings a wealth of knowledge and expertise to our organization,” said Chris Fikry, M.D., Chief Executive Officer at Clario. Jason himself shared the enthusiasm, stating, “Clario not only has a strong legacy but also is well-positioned to drive the next wave of innovation.”
Promotion of Lauren Misztal as SVP, General Counsel
Lauren Misztal, who joined Clario in 2022, has seen a swift elevation to SVP, General Counsel, reflecting her hard work and dedication. Lauren’s legal and compliance expertise spans several significant roles at Mallinckrodt Pharmaceuticals, McKesson Corporation, and Quinn Emanuel LLP, setting her up well for the new responsibilities at Clario.
Promotion of Dr. Joyce Suhy as EVP, Medical Imaging and Specialty Solutions
Recognizing the extraordinary contributions in the field of medical imaging, Clario has promoted Dr. Joyce Suhy to Executive Vice President, Medical Imaging and Specialty Solutions. With over 30 years of experience in the medical imaging field and significant contributions to Alzheimer’s disease-modifying drugs, Dr. Suhy has proven to be a pivotal figure within Clario’s Medical Imaging division.
Promotion of Kristina Lowe as SVP, Client Success & Customer Experience
Lastly, Kristina Lowe, with more than two decades of experience in clinical research, has been promoted to Senior Vice President, Client Success & Customer Experience. Kristina’s role in Clario’s customer relations and experience is vital, overseeing collaborations, nurturing a solution-oriented approach, and fostering understanding within the organization and the broader e-clinical landscape.
About Clario
Clario is a healthcare research and technology company known for generating rich clinical evidence for its pharmaceutical, biotech, and medical device partners. With a global team of science, technology, and operational experts, Clario has delivered over 27,000 trials and contributed to over 500 FDA and EMEA new drug approvals. Its commitment to innovation has been transforming clinical trials for the past 50 years.
For more information about Clario and its team, visit Clario.com.
